Glucokinase (GK) gene transcription initiates in the islet (␤-cell), gut, and brain from promoter sequences residing ϳ35 kbp upstream from those used in liver. Expression of ␤GK is controlled in ␤-cells by cellenriched (i.e. pancreatic duodenal homeobox 1 [PDX-1]) and ubiquitously (i.e., Pal) distributed factors that bind to and activate from conserved sequence motifs within the upstream promoter region (termed ␤GK). Here, we show that a conserved E-box element also contributes to control in the islet and gut. ␤GK promoter-driven reporter gene activity was diminished by mutating the specific sequences involved in E-boxmediated basic helix-loop-helix factor activator binding in islet ␤-cells and enteroendocrine cells. Gel shift assays demonstrated that the ␤GK and insulin gene E-box elements formed the same cell-enriched (BETA2: E47) and generally distributed (upstream stimulatory factor [USF]) protein-DNA complexes. ␤GK E-boxdriven activity was stimulated in cotransfection assays performed in baby hamster kidney (BHK) cells with BETA2 and E47, but not USF. Chromatin immunoprecipitation assays performed with BETA2 antisera showed that BETA2 occupies the upstream promoter region of the endogenous ␤GK gene in ␤-cells. We propose that BETA2 (also termed NeuroD1) regulates ␤GK promoter activity. Diabetes 52: [403][404][405][406][407][408] 2003 
G
lucose homeostasis in mammals appears to be maintained by a rare set of specialized cells distributed throughout the body, some of which sense glucose and respond by releasing hormones and/or neurotransmitters. Pancreatic islet ␤-cells are the most thoroughly studied glucose-sensing cell type. In ␤-cells, the rate-limiting step in the glucoseinduced signaling pathway is catalyzed by the enzyme glucokinase (␤GK). ␤GK is a member of a family of hexokinases that mediate the conversion of glucose to glucose-6-phosphate, the first step in glycolysis (1) . This low-affinity hexokinase is catalytically active within physiological glucose concentrations (4 -8 mmol/l) and is not inhibited by its enzymatically derived glucose-6-phosphate end product (2) . These mechanistic properties distinguish ␤GK from the more generally distributed low-K m hexokinases (type I-III) and are featured during the coupling of glucose metabolism to insulin secretion.
␤GK is also expressed in some gut enteroendocrine cells and neurons in the brain (3) (4) (5) (6) (7) . These cells are sparsely distributed yet strategically located in parts of the body and are thought to be involved in glucose sensing. For instance, ␤GK is found in the glucose-dependent insulinotropic peptide (GIP)-producing K cells in the duodenum (7) . Interestingly, when K cells were engineered to express insulin under the control of the GIP gene promoter, they functioned in place of ␤-cells to maintain whole-body glucose homeostasis (7) . Thus, it has been proposed that ␤GK may serve as the "glucose sensor" in the gut (7) and brain (8) .
GK mRNA is produced from two distinct promoters that are utilized in a tissue-specific manner. The upstream promoter is involved in ␤GK mRNA production in the pancreas, duodenum, pituitary, and brain, whereas the promoter ϳ35 kb downstream is used in liver (9) . Experiments performed in transgenic mice and cultured cell lines have shown that the cis-acting elements necessary for selective expression of the upstream promoter are located within 280 bp of the transcription initiation region (3,10 -12) . Two distinct sequence motifs have been shown to be functionally important in islet ␤-cells, referred to as upstream promoter element (UPE) and Pal sites (10, 13) . The UPEs are AϩT-rich elements that appear to be positively regulated by pancreatic duodenal homeobox 1 (PDX-1) (10, 14) , a homeodomain protein involved in pancreatic development and the transcription of genes essential for ␤-cell function, including insulin (15) and GLUT2 (16) . In contrast, the Pal motifs consist of two identical 4-bp inverted repeats separated by a single nucleotide (TGGTCACCA) (13) , and the stimulatory protein(s) has not been isolated.
In addition to the UPE and Pal sites, the sequence conservation between the mouse, rat, and human ␤GK genes indicated that other control sites existed within the upstream promoter region (17) . Here, we show that the conserved E-box element at position Ϫ221 to Ϫ216 relative to the transcription start site is also necessary for stimulation in ␤-cells and enteroendocrine cells. Gel shift and transfection experiments suggested that regulation of both the ␤GK and insulin E-box was mediated by the same set of proteins, an activator consisting of basic helix-loophelix (bHLH) proteins that are islet and neuronal cell enriched, BETA2 (also known as NeuroD1) (18) , and ubiquitously distributed E47. Chromatin immunoprecipitation (ChIP) analysis also showed that BETA2 binds in vivo to the ␤GK region. Because islet (19) , gut (19) , and brain development (20, 21) were all severely affected in BETA2-null mice, BETA2 may represent a common regulator of upstream promoter-mediated expression.
glycine was added to 125 mmol/l. Cells were washed with cold PBS, pelleted, and incubated in 0.6 ml of 1% SDS, 10 mmol/l EDTA, 50 mmol/l Tris-HCl (pH 8.1), and 1 mmol/l phenylmethylsulfonyl fluoride (PMSF) for 10 min on ice. The lysed samples were transferred to tubes containing 250-mg glass beads (Յ10 6 mm diameter) and treated at setting 4 with a Virsonic 100 sonicator (Virtis) for 12 10-s pulses at 4°C to fragment the chromatin. Then, 100-l aliquots were incubated with 0.9 ml dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mmol/l EDTA, 16.7 mmol/l Tris-HCl, pH 8.1, 167 mmol/l NaCl, 1 mmol/l PMSF, and 0.1% protease inhibitor cocktail for mammalian cells; Sigma) and 60 l of 50% protein G-Sepharose (blocked with 1 mg/ml BSA and 1 mg/ml sonicated salmon sperm DNA) for 1 h at 4°C. After removal of the Sepharose beads by centrifugation, 5 g anti-BETA2 (NeuroD1) polyclonal IgG (Santa Cruz Biotechnology), 10 g normal goat polyclonal IgG (Santa Cruz Biotechnology), or no antibody was added to the supernatant, and the reaction was incubated for 1 h at 4°C. Next, 60 l of 50% protein G-Sepharose was added, and the reaction was incubated at 4°C for 3 h. The Sepharose beads were collected by centrifugation and washed extensively. The formaldehyde-induced cross-linking was reversed by incubating the beads overnight at 65°C with 0.5 ml elution buffer (1% SDS and 0.1 mol/l NaHCO 3 ) and 20 l of 5 mol/l NaCl. The immunoprecipitated DNA was purified by standard methods and resuspended in 105 l of nuclease-free water (Promega). PCR analysis was performed using Ready-to-Go PCR beads (Amersham Pharmacia Biotech) with 15 pmol of each primer and 10 l of immunoprecipitated DNA per reaction. The cycling parameters were 1 cycle of 95°C (2 min) and 28 cycles of 95°C (30 s), 61°C (30 s), and 72°C (30 s). The primers used for amplification were: mouse ␤GK, Ϫ256 GTGATAGGCACCAAGGCACTGAC and Ϫ1 CGGTGCTTCTGTTCCAACCAGG; and phosphoenolpyruvate carboxykinase (PEPCK), 5Ј-GAGTGACACCTCACAGCTGTGG and 5Ј-GGCAG-GCCTTTGGATCATAGCC. The correctness of the PCR products was confirmed by sequencing. Amplified products were electrophoresed through a 1.4% agarose gel in Tris-acetate-EDTA buffer and visualized by ethidium bromide staining.
FIG. 1. The conserved E-box contributes in ␤GK promoter activity. A:
The relative position of the UPE (؊214/؊210, ؊131/؊126, and ؊102/ ؊97), Pal (؊168/؊160 and ؊90/؊82), and E (؊221/؊216) elements common to the mouse, rat, and human ␤GK genes (rat promoter shown). B: The conserved sequences within the E-box region. The invariant nucleotides required for bHLH activator binding are underlined; the site of mt1 (C to A) and mt2 (G to T) is shown. C: HIT T-15, MIN6, ␤TC3, RIN, and STC-1 cells were cotransfected with wild-type (wt) or mutant (mt1 or mt2) versions of the ؊402/؉14 bp luciferase expression plasmid, which is driven by rat ␤GK promoter sequences, and a Renilla luciferase (pRL-TK) internal control. pSVO represents the promoter-less vector. The normalized percent mutant ؊402/؉14 bp luciferase activity ؎ SD is presented relative to the wild type.
RESULTS
The conserved E-box in the upstream ␤GK promoter is important for activation. The region spanning the UPE and Pal control sites between Ϫ280 to ϩ14 bp of the upstream rat ␤GK promoter has been shown to be sufficient to drive ␤-cell-selective expression (10, 13) . To understand the role of the conserved E-box element at Ϫ221 to Ϫ216 bp in ␤GK expression, single-point mutants were constructed that should either disrupt (mt1) or have little effect (mt2) on the binding of the bHLH family of proteins that regulate E-box activity (Fig. 1B) (26) . Their effect on activation was compared with the Pal-1 site mutant (Ϫ170/ Ϫ161) and the wild-type Ϫ402/ϩ14 luciferase construct in transfected ␤GK-expressing islet ␤-cell (HIT T-15, MIN6, ␤TC3, and RIN) and enteroendocrine (STC-1) cell lines. The expression pattern of the mutant constructs was essentially the same between lines. The results showed that the predicted dysfunctional Ϫ221 bp mutation within the bHLH factor contact site reduced ␤GK promoterdriven activity by 55, 45, 49, 48 , and 35% in HIT T-15, MIN6, ␤TC3, RIN, and STC-1 cells, respectively, whereas the nonessential site mutation at Ϫ219 bp had little or no effect (Fig. 1C ) in the tested cell lines. The loss in E-box activity was comparable to the Pal-1 site mutant in HIT-15 ( Fig. 1C) and STC-1 (data not shown) cells. These results strongly suggested that bHLH factor(s) binding to the conserved E-box element at Ϫ221 to Ϫ216 bp was involved in ␤GK promoter activity within the islet and intestine. BETA2:E47 and USF bind in vitro to the ␤GK E-box.
The insulin E-box element is activated by a ␤-cell-enriched activator complex composed of BETA2 and E47 that contributes in cell-selective transcription (23, 27) . To characterize the factor(s) that bind to the ␤GK E-box element, gel mobility shift assays were performed with HIT T-15 nuclear extracts and probes to both the ␤GK and insulin E-box. Two major protein-DNA complexes (termed a and b) were shared between these elements ( Fig. 2A) . Competition assays performed with the unlabeled wild type and a consensus mtE indicated that each complex contained a bHLH binding factor(s) (Fig. 2A) . The a complex was only detected in ␤GK-expressing HIT T-15 and STC-1 nuclear extracts, whereas the b complex was also found in nuclear extracts prepared from nonexpressing cells (data not shown).
The bHLH factor complexes that bind in gel shift assays to the insulin E-box contain the cell-enriched BETA2 transcription factor (i.e. as BETA2:E47) and the ubiquitously distributed USF (27, 28) . To determine whether these proteins were involved in binding to the ␤GK E-box, a super-shift assay was performed with antibodies against BETA2, E47, and the two isoforms of USF (i.e. USF1 and USF2). The addition of antibodies to BETA2 or E47 to the binding reactions specifically disrupted the a complex, and a higher super-shifted complex was detected in each lane (Fig. 2B) . In contrast, the preimmune serum had no effect on complex formation. In addition, antibodies raised against USF1, but not USF2, selectively disrupted the b complex (compare U1 with U2 in Fig. 2C ). An unlabeled USF E-box consensus binding site competitor also specifically eliminated b complex binding (Fig. 2C) . These same complexes were detected in gel shift assays performed with MIN6 and ␤TC-3 nuclear extracts (data not shown). These results demonstrated that the two E-box element complexes contained BETA2:E47 (a complex) and USF-1 (b complex).
Methylation interference analysis was performed on the BETA2:E47 complex to identify the nucleotide contact sites within the ␤GK E-box element. The core CA and TG nucleotides were found to be the primary contact sites, although variant nucleotides were also contacted (Fig.  3A) . A similar in vitro binding pattern for BETA2:E47 has also been found with the E-box motifs of rat insulin I (29), rat insulin II (27) , pro-opiomelanocortin (POMC) (30) , and secretin (31) genes. Interestingly, both the Ϫ221 and Ϫ219 bp were strong contact sites (Fig. 3B) , although only the Ϫ221-bp mutation (i.e. mt1) within the invariant bHLH factor binding core affected E-box element activity in transfection (Fig. 1C ) and competition assays (Fig. 3C) . BETA2:E47 selectively activates the ␤GK E-box. To determine whether BETA2:E47 or USF1 could directly activate ␤GK E-box-mediated activation, we analyzed the effect of each upon expression of p␤GKEboxTATALuc, a reporter plasmid that contains three copies of the ␤GK 2 and 6), insulin (lanes 3  and 7), or mutant ␤GK mtE (lanes 4 and 8) competitor E-box inserted directly upstream of the promoter region in the pTATALuc reporter gene. p␤GKEboxTATALuc was transfected into BHK cells either alone or in the presence of the BETA2, E47, USF1, or USF2 expression plasmids. ␤GK E-box-mediated expression was stimulated by E47 alone but more effectively by E47 and BETA2 (Fig. 4A) . These factors did not affect the activity of the insert-less vector pTATALuc (Fig. 4B) . Furthermore, activation was not observed with BETA2, USF1, or USF2 alone (Fig. 4) . Because BETA2 and E47 only appear to be found together in cells (23) , these results strongly suggest the ␤GK E-box activity is mediated by this cell-enriched activator complex. BETA2 binds within the upstream ␤GK promoter region in vivo. The ChIP assay is a powerful tool for analyzing transcription factor binding in vivo (32, 33) . To directly address whether BETA2 binds to the upstream promoter of the endogenous ␤GK gene, formaldehyde crosslinked chromatin from ␤GK-expressing MIN6 ␤-cells was treated with BETA2 polyclonal IgG or goat polyclonal IgG. The DNA brought down by this treatment was PCR amplified with ␤GK and PEPCK promoter-specific primers. The antibody to BETA2 was capable of immunoprecipitating upstream ␤GK promoter sequences, whereas goat polyclonal IgG or the control without IgG could not (Fig. 5) . However, the BETA2 IgG did not immunoprecipitate transcription control sequences from the PEPCK gene, which is not transcribed in ␤-cells. These results demonstrate that BETA2 occupies the ␤GK promoter region of the endogenous ␤GK gene in ␤-cells. The same conclusion was drawn in ChIP experiments performed in ␤TC-3 cells (data not shown). Together with the gel shift and transfection data described above, these results demonstrate that BETA2 regulates ␤GK promoter-mediated transcription.
FIG. 2. BETA2:E47 and USF1 bind in vitro to the ␤GK E-box. A: ␤GK (lanes 1-4) and insulin (INS; lanes 5-8) E-box binding reactions were conducted with HIT-T15 nuclear extract either alone (-) or in the presence of a 10-fold molar excess to probe of the wildtype ␤GK (lanes

DISCUSSION
␤GK plays a critical role in adult islet ␤-cell function by catalyzing the rate-limiting step of glucose-induced insulin release (34) . ␤GK mRNA transcription in the islet, gut, pituitary, and brain is controlled by sequences in the upstream promoter region (10, 11, 13) . Experiments performed in transgenic mice have shown that tissue-specific expression is mediated by cis-acting elements found between Ϫ280 and ϩ14 bp (3) . Here, we show that a bHLH protein complex containing BETA2 and E47 regulates activation in islet ␤-cell and gut enteroendocrine cells from the conserved E-box element at Ϫ221/Ϫ216 bp.
Our initial strategy involved testing within a GK gene promoter construct spanning Ϫ402 to ϩ14 bp, the effect of site-directed mutants within the potential E-box element at Ϫ221 to Ϫ216 bp. Under these circumstances, a mutant that blocked bHLH protein binding reduced activation by ϳ50% in HIT T-15, ␤TC-3, MIN6, and RIN ␤-cell lines, whereas no effect was observed in a mutant that did not influence binding. In contrast, a previous study found that there was only an 18% decrease in activation in a 5Ј-flanking deletion mutant that removed this E-box region (10) . Most likely, sequences within the vector minimized the control features of the GK E-box in this study.
Both BETA2:E47 and USF-1 were shown to bind specifically to the ␤GK E-box probe in gel shift assays (Fig. 2) . To test their role in activation, the ability of BETA2, E47, USF-1, and USF-2 to stimulate ␤GK E-box-driven reporter expression was analyzed in BHK cells. E47 and BETA2 stimulated activity, in contrast to either of the USF proteins (Fig. 4) . Because the USF proteins independently bind to their DNA regulatory target (35) , their inability to activate indicates that they are not involved in ␤GK E-box control in vivo. Most significantly, BETA2 was shown to specifically bind to a region spanning the E-box within the endogenous ␤GK promoter, using the ChIP assay (Fig. 5) . These data strongly suggest that BETA2:E47 specifically binds to and activates the upstream ␤GK promoter in the islet and gut. BETA2:E47 has also been shown to control insulin (23) , glucagon (islet ␤-cells) (36), secretin (gut enteroendocrine cells) (31, 37) , and POMC (pituitary corticotropes) (38) gene expression in ␤GK-producing cell types.
In addition to its role as a transcriptional activator, BETA2 plays a significant role in the development of the pancreas, brain, and other gut endocrine cells. Targeted deletion of BETA2 in mice, for instance, results in compromised formation of islet cells (23) , hippocampal and cerebellar neurons (39) , and both secretin-and cholecystokinin-expressing enteroendocrine cells (37) . Although ␤GK expression has not been fully analyzed in BETA2-null mice, the overlapping expression pattern of BETA2 with ␤GK-producing cells in affected tissues implies a potential role of BETA2 in controlling ␤GK gene transcription.
Because the E-box, Pal, and UPE elements appear to be maintained within the upstream transcription unit of all mammalian ␤GK genes (17), the conserved sequences within this region are likely to contain the binding sites for the other key factors required in transcriptional activation. Indeed, our experimental results suggest that selective transcription from the ␤GK promoter results from BETA2 cooperating with other factor(s) having a more cell-restricted expression pattern. It is likely that control is mediated through functional interactions with the PDX-1 homeodomain protein that binds to the three AϩT-rich UPE elements of ␤GK (10, 40) . PDX-1 contributes in transcription of other ␤-cell-enriched genes, including insulin (15, 41) , islet amyloid polypeptide (42) (43) (44) , and GLUT2 (16) . In the insulin gene, activation by BETA2:E47 and PDX-1 is mediated by the p300/CBP (CREB binding protein) coactivator (45) , a mechanism that also may be utilized in the ␤GK promoter.
Dysfunctional mutations in the coding region of GK are linked to a form of diabetes, termed maturity-onset diabetes of the young-type 2 (MODY-2) (46). Although GK was the first MODY locus discovered, the genetic basis for several other MODY subtypes were identified as transcription factors, including PDX-1 (47) . Heterozygous mutations in PDX-1 in mice results in glucose intolerance (48) . The inability to provide insulin in sufficient amounts to meet the body's needs is also found in a form of type 2 diabetes caused by mutations in BETA2 (49) . Our results indicate that conditions that effect the level or function of a factor involved in GK gene expression, like BETA2 and/or PDX-1, could also compromise ␤-cell function.
